Table 4.
Facial paresis (present vs absent) and quality of life domains of the PANQOL
| PANQOL domain | No facial paresis | Facial paresis | BF | t | P | d |
|---|---|---|---|---|---|---|
| M (SD) | M (SD) | |||||
| PANQOL total score | 70.99 (16.95) | 64.19 (17.50) | 10.32 | 1.35 | .092 | 0.39 |
| Anxiety | 80.90 (15.83) | 79.10 (14.50) | 0.52 | 0.41 | .343 | 0.12 |
| Facial functioning | 88.04 (23.14) | 59.84 (19.12) | 399 355.37 | 4.56 | <.001 | 1.33 |
| General health | 29.89 (27.88) | 31.25 (22.12) | 0.74 | −0.19 | .573 | 0.05 |
| Balance | 67.39 (31.40) | 64.76 (24.01) | 1.68 | 0.32 | .374 | 0.09 |
| Hearing loss | 56.52 (27.27) | 56.51 (27.30) | 1.00 | 0.00 | .500 | 0.00 |
| Energy | 74.52 (17.17) | 63.73 (22.31) | 30.38 | 1.85 | .035 | 0.54 |
| Pain | 85.87 (28.03) | 76.04 (36.47) | 5.63 | 1.03 | .154 | 0.30 |
Note: BF for the hypothesis that VS patients with facial paresis experience lower health‐related quality of life than VS patients without facial paresis. P represents significance based on directional (one‐tailed) t‐test.
Abbreviation: BF, Bayesian factor.